Idiopathic Arginine Vasopressin Deficiency With Mild and Reversible Hypercalcemia

REFERENCES

1. 1.↵
   1. Christ-Crain M,
   2. Winzeler B,
   3. Refardt J

   . Diagnosis and management of diabetes insipidus for the internist: an update. J Intern Med. 2021;290(1):73-87. doi: 10.1111/joim.13261

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Robertson GL

   . Diabetes insipidus. Endocrinol Metab Clin North Am. 1995;24(3):549-572.

   OpenUrlPubMedWeb of Science
3. 3.↵
   1. Tysoe O

   . Patients' insights into diabetes insipidus. Nat Rev Endocrinol. 2022;18(11):657. doi: 10.1038/s41574-022-00751-x

   OpenUrlCrossRef
4. 4.↵
   1. Christ-Crain M,
   2. Bichet DG,
   3. Fenske WK,
   4. et al.

   Diabetes insipidus. Nat Rev Dis Primers. 2019;5(1):54. doi: 10.1038/s41572-019-0103-2

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Moeller HB,
   2. Rittig S,
   3. Fenton RA

   . Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment. Endocr Rev. 2013;34(2):278-301. doi: 10.1210/er.2012-1044

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Khositseth S,
   2. Charngkaew K,
   3. Boonkrai C,
   4. et al.

   Hypercalcemia induces targeted autophagic degradation of aquaporin-2 at the onset of nephrogenic diabetes insipidus. Kidney Int. 2017;91(5):1070-1087. doi: 10.1016/j.kint.2016.12.005

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Khairallah W,
   2. Fawaz A,
   3. Brown EM

   , El-Hajj Fuleihan G. Hypercalcemia and diabetes insipidus in a patient previously treated with lithium. Nat Clin Pract Nephrol. 2007;3(7):397-404. doi: 10.1038/ncpneph0525

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Nussbaum SR

   . Pathophysiology and management of severe hypercalcemia. Endocrinol Metab Clin North Am. 1993;22(2):343-362. doi: 10.1016/S0889-8529(18)30170-1

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Mariani LH,
   2. Berns JS

   . The renal manifestations of thyroid disease. J Am Soc Nephrol. 2012;23(1):22-26. doi: 10.1681/ASN.2010070766

   OpenUrlAbstract/FREE Full Text
10. 10.
    1. Muthukrishnan J,
    2. Saurabh D

    . An unusual cause of polyuria. Indian J Endocrinol Metab. 2012;16(6):1051-1052. doi: 10.4103/2230-8210.103042

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Singla M,
    2. Gupta A

    . An overlooked cause of polyuria. Am J Med. 2019;132(2):e33-e34. doi: 10.1016/j.amjmed.2018.09.035

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Fernandes LG,
    2. Ferreira NR,
    3. Cardiga R,
    4. Póvoa P

    . Severe hypercalcaemia and colon ischaemia: dehydration as an unusual cause? BMJ Case Rep. 2015;2015:bcr2014208809. doi: 10.1136/bcr-2014-208809

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. Acharya R,
    2. Winters DM,
    3. Rowe C,
    4. Buckley N,
    5. Kafle S,
    6. Chhetri B

    . An unusual case of severe hypercalcemia: as dehydrated as a bone. J Community Hosp Intern Med Perspect. 2021;11(1):135-138. doi: 10.1080/20009666.2020.1851859

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Ishunina TA,
    2. Swaab DF

    . Vasopressin and oxytocin neurons of the human supraoptic and paraventricular nucleus: size changes in relation to age and sex. J Clin Endocrinol Metab. 1999;84(12):4637-4644. doi: 10.1210/jcem.84.12.6187

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Ranieri M,
    2. Di Mise A,
    3. Tamma G,
    4. Valenti G

    . Vasopressin-aquaporin-2 pathway: recent advances in understanding water balance disorders. F1000Res. 2019;8:F1000 Faculty Rev-149. doi: 10.12688/f1000research.16654.1

    OpenUrlCrossRef
16. 16.↵
    1. Working Group for Renaming Diabetes Insipidus
    2. Arima H,
    3. Cheetham T,
    4. et al.

    Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus. Endocr J. 2022;69(11):1281-1284. doi: 10.1507/endocrj.EJ20220831

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Prentice M

    . Time for change: renaming diabetes insipidus to improve patient safety. Clin Endocrinol (Oxf). 2018;88(5):625-626. doi: 10.1111/cen.13578

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Levy M

    . Renaming diabetes insipidus. Endocrinologist. 2022;146. Accessed September 27, 2024. endocrinology.org/endocrinologist/146-winter-22/general-news/renaming-diabetes-insipidus/
19. 19.↵
    1. Refardt J,
    2. Winzeler B,
    3. Christ-Crain M

    . Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis. Clin Endocrinol (Oxf). 2019;91(1):22-32. doi: 10.1111/cen.13991

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Timper K,
    2. Fenske W,
    3. Kühn F,
    4. et al.

    Diagnostic accuracy of copeptin in the differential diagnosis of the polyuria-polydipsia syndrome: a prospective multicenter study. J Clin Endocrinol Metab. 2015;100(6):2268-2274. doi: 10.1210/jc.2014-4507

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Decaux G,
    2. Prospert F,
    3. Namias B,
    4. Soupart A

    . Hyperuricemia as a clue for central diabetes insipidus (lack of V1 effect) in the differential diagnosis of polydipsia. Am J Med. 1997;103(5):376-382. doi: 10.1016/s0002-9343(97)00165-4

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Pivonello R,
    2. De Bellis A,
    3. Faggiano A,
    4. et al.

    Central diabetes insipidus and autoimmunity: relationship between the occurrence of antibodies to arginine vasopressin-secreting cells and clinical, immunological, and radiological features in a large cohort of patients with central diabetes insipidus of known and unknown etiology. J Clin Endocrinol Metab. 2003;88(4):1629-1636. doi: 10.1210/jc.2002-020791

    OpenUrlCrossRefPubMed
23. 23.
    1. Hannon MJ,
    2. Orr C,
    3. Moran C,
    4. et al.

    Anterior hypopituitarism is rare and autoimmune disease is common in adults with idiopathic central diabetes insipidus. Clin Endocrinol (Oxf). 2012;76(5):725-728. doi: 10.1111/j.1365-2265.2011.04270.x

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Tomkins M,
    2. Lawless S,
    3. Martin-Grace J,
    4. Sherlock M,
    5. Thompson CJ

    . Diagnosis and management of central diabetes insipidus in adults. J Clin Endocrinol Metab. 2022;107(10):2701-2715. doi: 10.1210/clinem/dgac381

    OpenUrlCrossRefPubMed